This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richmond T. Prehn, MD; Liisa M. Prehn, MD

Arch Surg. 1989;124(1):102-106.

Abstract
• A large amount of data suggest that tumors are, to some degree, dependent for their growth on a positive level of immune reaction, a level that is unique for each tumor. Each tumor gradually adjusts its immunogenicity to the level that will, in the immunologic context of its own particular host, maximize its growth. Thus, it follows that immunosuppression may be as likely as immunoaugmentation to have a therapeutic effect.

(Arch Surg 1989;124:102-106)

Author Affiliations
From the Department of Pathology, University of Washington, Seattle.

Footnotes
Accepted for publication Aug 26, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 24, 1988.

Reprint requests to Department of Pathology, University of Washington, Seattle, WA 98195 (Dr R. Prehn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?